Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

22.10.21	U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines (PR Newswire)
21.10.21	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021 (PR Newswire)
21.10.21	FDA Authorizes Johnson & Johnson And Moderna Booster Shots (RTTNews)
21.10.21	Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA (PR Newswire)
19.10.21	Will FDA Allow 'mix And Match' Of Covid Booster Shots? (RTTNews)
19.10.21	Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market (RTTNews)
19.10.21	Johnson & Johnson Q3 adjusted earnings Beat Estimates (RTTNews)
19.10.21	Johnson & Johnson Reports Q3 2021 Results (PR Newswire)
15.10.21	FDA Panel Unanimously Recommends J&J Covid Booster Shot (RTTNews)
15.10.21	Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee (PR Newswire)
15.10.21	Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme (PR Newswire)
14.10.21	Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims (PR Newswire)
14.10.21	FDA Panel Convenes To Discuss Requirement Of Moderna Vaccine Booster Shots (RTTNews)
13.10.21	Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals (PR Newswire)
12.10.21	Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations (PR Newswire)
12.10.21	Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 (PR Newswire)
11.10.21	Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference (PR Newswire)
06.10.21	Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue (RTTNews)
06.10.21	Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature (PR Newswire)
05.10.21	Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine (RTTNews)
05.10.21	Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine (PR Newswire)
28.09.21	Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes (PR Newswire)
21.09.21	J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection (RTTNews)
21.09.21	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. (PR Newswire)
16.09.21	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (PR Newswire)
14.09.21	Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response (RTTNews)
14.09.21	Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases (PR Newswire)
02.09.21	Battle Against Johnson & Johnson "Texas Two-Step" Ploy Moves to New Jersey (PR Newswire)
01.09.21	FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts (RTTNews)
31.08.21	Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict (PR Newswire)
31.08.21	Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study (RTTNews)
31.08.21	Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa (PR Newswire)
26.08.21	Johnson & Johnson Seeks Global Nominees for Award Geared at Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design (PR Newswire)
26.08.21	Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference (PR Newswire)
25.08.21	J&J COVID-19 Vaccine Booster Dose Rapidly Boosted Spike-binding Antibodies (RTTNews)
25.08.21	Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine (PR Newswire)
24.08.21	Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan (PR Newswire)
20.08.21	Alex Gorsky To Step Down As J&J's CEO And Joaquin Duato To Take Over CEO Role (RTTNews)
19.08.21	Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 (PR Newswire)
12.08.21	Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference (PR Newswire)
09.08.21	Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference (PR Newswire)
08.08.21	India Approves Johnson & Johnson's Single-dose COVID-19 Vaccine (RTTNews)
29.07.21	Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney (PR Newswire)
29.07.21	FDA Extends Shelf-life Of Johnson & Johnson's COVID-19 Vaccine (RTTNews)
27.07.21	Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference (PR Newswire)
21.07.21	Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal (RTTNews)
21.07.21	Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates (RTTNews)
21.07.21	Johnson & Johnson Q2 adjusted earnings Beat Estimates (RTTNews)
21.07.21	Johnson & Johnson Reports Q2 2021 Results (PR Newswire)
20.07.21	Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	76.42	2.03 %	K V
CieFinRichemont	136.90	1.97 %	K V
UBS Group	28.92	1.62 %	K V
Part Grp Hldg	1’258.50	1.04 %	K V
Sika	214.90	0.94 %	K V
Swiss Life Hldg	707.60	-0.70 %	K V
Swiss Re	131.20	-1.13 %	K V
Nestle	73.72	-1.31 %	K V
Sonova Hldg	292.10	-1.45 %	K V
Givaudan	3’866.00	-2.00 %	K V

mehr

10:53		CureVac-Aktie springt an: Strategischer Fokus auf Forschung und Innovation
10:02		SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 5 Jahren abgeworfen
10:02		DAX 40-Titel Beiersdorf-Aktie: So viel hätte eine Investition in Beiersdorf von vor 3 Jahren abgeworfen
10:02		DAX 40-Titel Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 5 Jahren eingebracht
10:02		DAX 40-Wert Merck-Aktie: So viel hätte eine Investition in Merck von vor 10 Jahren abgeworfen
09:28		SPI-Handel aktuell: SPI legt zum Start des Montagshandels zu
09:28		SLI-Handel aktuell: SLI startet mit Gewinnen
09:28		STOXX 50-Handel aktuell: STOXX 50 steigt zum Start des Montagshandels

10:53

CureVac-Aktie springt an: Strategischer Fokus auf Forschung und Innovation

10:02

SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 5 Jahren abgeworfen

10:02

DAX 40-Titel Beiersdorf-Aktie: So viel hätte eine Investition in Beiersdorf von vor 3 Jahren abgeworfen

10:02

DAX 40-Titel Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 5 Jahren eingebracht

10:02

DAX 40-Wert Merck-Aktie: So viel hätte eine Investition in Merck von vor 10 Jahren abgeworfen

09:28

SPI-Handel aktuell: SPI legt zum Start des Montagshandels zu